Increased genetic knowledge has redefined precision medicine and therapeutic landscapes. Menarini Group is well positioned for a future of precision cancer care, where patients are given access to treatment options that are personalised to their individual needs. By creating and building innovative approaches, we seek to provide optimal care to patients with different cancers and make it accessible to everyone across the world.

At Menarini Asia-Pacific, our own oncology journey began with our in-licensing breakthrough cancer pain portfolio. Driven by our manifesto, “Committed to make a difference in Cancer Patients’ Lives”, we constantly invest in research development and work with valued stakeholders to deliver extraordinary service and cutting-edge resources to cancer patients and healthcare providers.